Constance Keyserling

1.2k total citations
29 papers, 780 citations indexed

About

Constance Keyserling is a scholar working on Epidemiology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Constance Keyserling has authored 29 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Constance Keyserling's work include Pneumonia and Respiratory Infections (8 papers), Lipoproteins and Cardiovascular Health (7 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Constance Keyserling is often cited by papers focused on Pneumonia and Respiratory Infections (8 papers), Lipoproteins and Cardiovascular Health (7 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Constance Keyserling collaborates with scholars based in United States, Netherlands and United Kingdom. Constance Keyserling's co-authors include Kenneth J. Tack, Jean‐Louis Dasseux, Ronald Barbaras, John F. Paolini, Mary Anne Nemeth, James McCarty, James Hedrick, W M Gooch, Rudi Baron and Loek P. Smits and has published in prestigious journals such as Circulation, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Constance Keyserling

29 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Constance Keyserling United States	19	317	240	225	143	132	29	780
J. Vergniol France	13	110 0.3×	642 2.7×	72 0.3×	53 0.4×	31 0.2×	32	1.2k
Mithra Baliga United States	14	160 0.5×	335 1.4×	28 0.1×	160 1.1×	41 0.3×	38	994
Thiruvengadam Muniraj United States	17	610 1.9×	245 1.0×	32 0.1×	51 0.4×	67 0.5×	77	1.1k
Per Olov Hedlund Sweden	17	110 0.3×	93 0.4×	113 0.5×	28 0.2×	61 0.5×	53	714
Martina Gambato Italy	21	334 1.1×	763 3.2×	88 0.4×	70 0.5×	58 0.4×	94	1.2k
Paolo Malvezzi France	19	280 0.9×	219 0.9×	24 0.1×	126 0.9×	20 0.2×	93	1.1k
Dushyant Singh Dahiya United States	14	294 0.9×	185 0.8×	48 0.2×	70 0.5×	20 0.2×	187	775
Xing Ai China	15	152 0.5×	130 0.5×	78 0.3×	126 0.9×	92 0.7×	40	743
Kapil Chopra United States	18	356 1.1×	674 2.8×	105 0.5×	53 0.4×	28 0.2×	39	1.2k
Ziv Ben Ari Israel	16	201 0.6×	806 3.4×	47 0.2×	245 1.7×	22 0.2×	38	1.3k

Countries citing papers authored by Constance Keyserling

Since Specialization

Citations

This map shows the geographic impact of Constance Keyserling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constance Keyserling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constance Keyserling more than expected).

Fields of papers citing papers by Constance Keyserling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constance Keyserling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constance Keyserling. The network helps show where Constance Keyserling may publish in the future.

Co-authorship network of co-authors of Constance Keyserling

This figure shows the co-authorship network connecting the top 25 collaborators of Constance Keyserling. A scholar is included among the top collaborators of Constance Keyserling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constance Keyserling. Constance Keyserling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Kang H., Yannick Kaiser, Raúl D. Santos, et al.. (2020). No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis. 311. 13–19. 23 indexed citations

Kataoka, Yu, Jordan Andrews, MyNgan Duong, et al.. (2017). Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden. Cardiovascular Diagnosis and Therapy. 7(3). 252–263. 43 indexed citations

Keyserling, Constance, Ronald Barbaras, Renée Benghozi, & Jean‐Louis Dasseux. (2017). Development of CER-001: Preclinical Dose Selection Through to Phase I Clinical Findings. Clinical Drug Investigation. 37(5). 483–491. 25 indexed citations

Zheng, Kang H., Fleur M. van der Valk, Loek P. Smits, et al.. (2016). HDL mimetic CER-001 targets atherosclerotic plaques in patients. Atherosclerosis. 251. 381–388. 52 indexed citations

Tardy, Claudine, Nadia Boubekeur, Rose Ackermann, et al.. (2015). HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation. PLoS ONE. 10(9). e0137584–e0137584. 26 indexed citations

Hovingh, G. Kees, Loek P. Smits, Claudia Stefanutti, et al.. (2015). The effect of an apolipoprotein A-I–containing high-density lipoprotein–mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia. American Heart Journal. 169(5). 736–742.e1. 57 indexed citations

Kootte, Ruud S., Loek P. Smits, Fleur M. van der Valk, et al.. (2015). Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA. Journal of Lipid Research. 56(3). 703–712. 75 indexed citations

Tardy, Claudine, Nadia Boubekeur, Rose Ackermann, et al.. (2013). CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice. Atherosclerosis. 232(1). 110–118. 92 indexed citations

Keyserling, Constance, Thomas L. Hunt, Robert A. Scott, et al.. (2011). Abstract 15525: CER-001, a Synthetic HDL-Mimetic, Safely Mobilizes Cholesterol in Healthy Dyslipidemic Volunteers. Circulation. 124. 13 indexed citations

10.

Glauser, M. P., U. Brennscheidt, Oliver A. Cornely, et al.. (2002). Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients. Clinical Microbiology and Infection. 8(1). 14–25. 5 indexed citations

11.

Fogarty, Charles, et al.. (2000). Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy. 45(6). 851–858. 18 indexed citations

12.

Adler, Michael, et al.. (2000). Cefdinir vs. amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children. The Pediatric Infectious Disease Journal. 19(Supplement). S166–S170. 26 indexed citations

13.

Block, Stan L., James McCarty, James Hedrick, et al.. (2000). Comparative safety and efficacy of cefdinir vs. amoxicillin/clavulanate for treatment of suppurative acute otitis media in children. The Pediatric Infectious Disease Journal. 19(Supplement). S159–S165. 47 indexed citations

14.

Herwaarden, C.L.A. van, et al.. (2000). International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis. International Journal of Infectious Diseases. 4(1). 26–33. 7 indexed citations

15.

Nemeth, Mary Anne, et al.. (2000). Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection. Clinical Therapeutics. 22(7). 818–825. 26 indexed citations

16.

Nemeth, Mary Anne, et al.. (1999). Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitis. Clinical Therapeutics. 21(9). 1525–1532. 20 indexed citations

17.

Nemeth, Mary Anne, James McCarty, W M Gooch, et al.. (1999). Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Clinical Therapeutics. 21(11). 1873–1881. 23 indexed citations

18.

Tack, Kenneth J., et al.. (1998). Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. Clinical Therapeutics. 20(2). 244–256. 28 indexed citations

19.

Adler, Michael, et al.. (1997). Cefdinir versus amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children. European Journal of Clinical Microbiology & Infectious Diseases. 16(3). 214–219. 15 indexed citations

20.

Griffin, Timothy J., et al.. (1996). Efficacy and safety of cefdinir in the treatment of patients with acute bronchitis. Clinical Therapeutics. 18(4). 626–634. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact